Vol 8, No 3 (June 30, 2019) - Translational Lung Cancer Research

Editorial

In memoriam: Professor Adi F. Gazdar, a pre-eminent pathologist and devoted man

Nico van Zandwijk, Michele Carbone, Translational Lung Cancer Research Editorial Office

PDF Pages: 200-201 Full Text (1598) Open Access

Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice

Sawsan Rashdan, David E. Gerber

PDF Pages: 202-207 Full Text (2760) Open Access

Original Article

18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis

Ming Zhao, Xiao-Feng Xin, Huan Hu, Xian-Hui Pan, Tang-Feng Lv, Hong-Bing Liu, Jian-Ya Zhang, Yong Song

PDF Pages: 208-213 Full Text (2028) Open Access

Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis

Zimu Wang, Ping Zhan, Yanling Lv, Kaikai Shen, Yuqing Wei, Hongbing Liu, Yong Song

PDF Pages: 214-226 Full Text (3151) Open Access

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer

Akihiro Yoshimura, Junji Uchino, Koichi Hasegawa, Taisuke Tsuji, Shinsuke Shiotsu, Tatsuya Yuba, Chieko Takumi, Tadaaki Yamada, Koichi Takayama, Noriya Hiraoka

PDF Pages: 227-234 Full Text (2652) Open Access

Whole genome sequencing revealed microbiome in lung adenocarcinomas presented as ground-glass nodules

Yijiu Ren, Hang Su, Yunlang She, Chenyang Dai, Dong Xie, Shavira Narrandes, Shujung Huang, Chang Chen, Wayne Xu

PDF Pages: 235-246 Full Text (3128) Open Access

A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer

Takefumi Komiya, Regan M. Memmott, Gideon M. Blumenthal, Wendy Bernstein, Marc S. Ballas, Roopa De Chowdhury, Guinevere Chun, Cody J. Peer, William D. Figg, David J. Liewehr, Seth M. Steinberg, Giuseppe Giaccone, Eva Szabo, Shigeru Kawabata, Junji Tsurutani, Arun Rajan, Phillip A. Dennis

PDF Pages: 247-257 Full Text (2234) Open Access

Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study

Irena Tan, Thomas E. Stinchcombe, Neal E. Ready, Jeffrey Crawford, Michael B. Datto, Rebecca J. Nagy, Richard B. Lanman, Lin Gu, Jeffrey M. Clarke

PDF Pages: 258-267 Full Text (7578) Open Access

EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases

Kai Dong, Wenhua Liang, Shen Zhao, Minzhang Guo, Qihua He, Caichen Li, Haiqing Song, Jianxing He, Xiaojun Xia

PDF Pages: 268-279 Full Text (3317) Open Access

Study Protocol

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Robert A. Belderbos, Paul Baas, Rossana Berardi, Robin Cornelissen, Dean A. Fennell, Jan P. van Meerbeeck, Arnaud Scherpereel, Heleen Vroman, Joachim G. J. V. Aerts, on behalf of the DENIM team

PDF Pages: 280-285 Full Text (4059) Open Access